FDA Clears Vivace RF Microneedling System at 2MHz Setting

Aesthetics Biomedical announces that the Vivace RF Microneedling device is now cleared for use at both the 1MHz and the 2MHz frequency.

The additional FDA clearance provides broad flexibility to choose either 1MHz or 2MHz for a patient’s treatment. Aesthetics Biomedical’s latest generation of FDA cleared, radiofrequency microneedling technology, Vivace, is designed to give patients visibly brighter, more radiant skin.

This minimally invasive treatment stimulates the natural production of collagen and has been shown by physicians, when using the 1MHz frequency, to be effective in alleviating facial wrinkles, fine lines, improving skin texture, tightening and toning the face and neck, for an overall glow, the company explains in a media release.

“ABM will make available to all practices that utilize the Vivace device with only 1MHz the opportunity to add the 2MHz setting, if desired. Our goal is to provide a best-in-class device with multiple features to address consumer needs.”

— Aesthetics Biomedical’s Founder and Chief Executive Officer, MaryAnn Guerra

[Source(s): Aesthetics Biomedical, PRWeb]